Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gastritis, Atrophic × Eflornithine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroblastoma 5 Prostatic Neoplasms 3 Skin Neoplasms 2 Precancerous Conditions 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Sarcoma, Ewing 1 Osteosarcoma 1 Non-melanoma Skin Cancer 1 Neoplasms 1 Medulloblastoma 1 Keratosis, Actinic 1 Gastritis, Atrophic 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1 Adenomatous Polyps 1 Adenomatous Polyposis Coli 1

Interventions

Eflornithine 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02794428 2024-10-16

Chemoprevention of Gastric Carcinogenesis

Vanderbilt-Ingram Cancer Center

Phase 2 Completed

91 enrolled 10 charts

Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡